Pantoprazole Related Compound B (25 mg) (5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole);Pantoprazole Thioether;5-(DifluoroMethoxy)-2-(((3,4-diMethoxypyridin-2-yl)Methyl)thio)-1H-benzo[d]iMidazole;Pantoprazole EP IMpurity-B (USP RC B);5-DIFLUOROMETHOXY-2-[(3,4-DIMETHOXY-2-PYRIDINYL)METHYL]THIO-1H-BENZIMIDAZOLE PANTOPRAZOLE SULFIDE;Pantoprazole EP IMpurity B;5-DifluoroMethoxy-2-[(3,4-diMethoxy-2-pyridyl)Methyl]thio-1H-benziMidazole, 95%;Pantoprazole Sulfide (Pantoprazole IMpurity B)
CAS号:
102625-64-9
分子式:
C16H15F2N3O3S
分子量:
367.37
EINECS号:
1806241-263-5
相关类别:
Intermediates & Fine Chemicals;Metabolites & Impurities;Pharmaceuticals;苯并杂环;医药中间体;左旋泮托拉唑硫醚;中间体;医药原料;原料;消化系统;原料药;合成;(intermediate of pantoprazole);Various Metabolites and Impurities;Metabolites;Pantoprazole Sodium
Mol文件:
102625-64-9.mol
公司简介
微巨实业是一家以研发，生产和销售一体的科技公司。公司与业内多家知名药企达成战略合作，致力于为客户提供优质的产品和专业的服务，可接受客户的供应商审计需求。
技术创新，建立竞争优势;专业服务创造顾客价值。
我们产品管线专注于以下领域的药物：
1核糖核苷衍生物在抗肿瘤、抗病毒领域；
2神经系统疾病药物
3高血压、糖尿病药物
4 生物医药领域中间体产品
加强自主创新能力和持续投资，是提高我们核心竞争力的关键性战略之一。
愿与所有客户携手合作，共同成长
Micro-mega is a based the research and development and innovation-driven company. We are committed to provide best quality product and professional service to meet customer require. Technology Innovation Establish Competitive Advantage and Professional Service Create Customer’s Value.
In the pharmaceutical industry, we focus on the following drugs:
1 The Ribose and Nucleoside Derivatives in the field of anti-cancer and anti-viral;
2 The Nervous System disease drugs
3 The Hypertension, Diabetes drugs
4 Biological medicine field of intermediate products
It is one of key strategies of us to improve our core competition ability by strengthening the independent innovation capability and continuous investment. We wish to cooperate with all customers and grow together.
